PBYI insider transaction filings
PUMA BIOTECHNOLOGY, INC. — 38 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-08. Screen PBYI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 8,460 @ $8.26 | EDGAR |
| 2026-07-08 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 9,386 @ $8.26 | EDGAR |
| 2026-07-08 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 44,058 @ $8.26 | EDGAR |
| 2026-06-15 | 4 | WILSON TROY EDWARD — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 10,800 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Stuglik Brian M — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 8,100 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Senderowicz Adrian — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 27,000 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Dorval Allison — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 11,610 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Cesano Alessandra — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2026-06-15 | 4 | MILLER MICHAEL PATRICK — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2026-06-15 | 4 | MOYES JAY M — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 22,000 @ $7.22 | EDGAR |
| 2026-02-20 | 4 | HUNT DOUGLAS M — See Remarks | Grant/award (A): 49,394 @ $0 · Grant/award (A): 70,321 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Grant/award (A): 46,739 @ $0 · Grant/award (A): 66,541 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Grant/award (A): 159,778 @ $0 · Grant/award (A): 227,474 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 3,973 @ $5.84 · Sale (S): 5,014 @ $5.88 | EDGAR |
| 2026-01-08 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 4,540 @ $5.84 · Sale (S): 6,405 @ $5.88 | EDGAR |
| 2026-01-08 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 16,938 @ $5.84 · Sale (S): 18,012 @ $5.88 | EDGAR |
| 2025-11-13 | 4 | MILLER MICHAEL PATRICK — Director | Sale (S): 20,000 @ $4.86 | EDGAR |
| 2025-07-22 | 4 | Cesano Alessandra — Director | Sale (S): 27,000 @ $3.37 | EDGAR |
| 2025-07-10 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 5,587 @ $3.53 · Sale (S): 3,935 @ $3.54 | EDGAR |
| 2025-07-10 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 4,374 @ $3.53 · Sale (S): 3,443 @ $3.54 | EDGAR |
| 2025-07-10 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 25,592 @ $3.53 · Sale (S): 21,580 @ $3.54 | EDGAR |
| 2025-06-17 | 4 | WILSON TROY EDWARD — Director | Sale (S): 10,800 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | Stuglik Brian M — Director | Sale (S): 8,100 @ $3.39 | EDGAR |
| 2025-06-17 | 4 | Senderowicz Adrian — Director | Sale (S): 27,000 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | Dorval Allison — Director | Sale (S): 11,610 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | Cesano Alessandra — Director | Sale (S): 12,150 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | MOYES JAY M — Director | Sale (S): 22,000 @ $3.40 | EDGAR |
| 2025-06-13 | 4 | Senderowicz Adrian — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | Dorval Allison — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | Stuglik Brian M — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | WILSON TROY EDWARD — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | Cesano Alessandra — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | MILLER MICHAEL PATRICK — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | MOYES JAY M — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-02-11 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Grant/award (A): 61,456 @ $0 · Grant/award (A): 85,067 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Ludwig Jeffrey Jerome — Chief Commercial Officer | Grant/award (A): 47,841 @ $0 · Grant/award (A): 66,221 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | HUNT DOUGLAS M — See Remarks | Grant/award (A): 48,117 @ $0 · Grant/award (A): 66,604 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Grant/award (A): 198,399 @ $0 · Grant/award (A): 274,622 (derivative) @ $0 | EDGAR |
Recent 8-K events — PUMA BIOTECHNOLOGY, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-24 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PBYI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →